Kyntra Bio, Inc. develops therapies for oncology and rare diseases. The company focuses on creating treatments for serious and life-threatening conditions and is involved in clinical trials to evaluate the efficacy of its products. Kyntra Bio emphasizes scientific rigor and operational excellence in its approach to therapy development.
